On December 1, 2021 Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat cancers, reported that the company will present at the RBC Capital Markets Healthcare Private Company Conference, taking place virtually on December 15-16, 2021 (Press release, Sapience Therapeutics, DEC 1, 2021, View Source [SID1234596364]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Barry Kappel, CEO and President, will participate in a fireside chat on December 16, 2021 at 2:30 PM ET. In addition, company management will participate in one-on-one meetings with life science investors during the event.